Business · 11/02/2002Updated: 10/17/2026 · 1 min read
Aventis Pharmaceuticals and Others See FDA Withdraw Approval of 12 New Drug Applications
Summary
The FDA is withdrawing approval of 12 new drug applications after the holders notified the agency that the drug products are no longer being marketed, requesting the withdrawal of approval.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →